Skip to main content
. 2014 Jan 20;2014(1):CD010927. doi: 10.1002/14651858.CD010927

1.15. Analysis.

1.15

Comparison 1 Dihydroartemisinin‐piperaquine versus Artesunate plus mefloquine, Outcome 15 Sensitivity analysis: Total failure Day 63 PCR‐adjusted.